S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The aim of this study is to investigate clinical effects (liver biochemistries, health-related quality of life, liver stiffness) and underlying mechanisms of hepatoprotection of S-adenosylmethionine in patients with primary sclerosing cholangitis. The study will be performed in a randomized and placebo-controlled fashion.
Epistemonikos ID: be5b338ebf448a79b7b89e8bb6a9d27c6356dc5a
First added on: May 15, 2024